Fiona Angela Marston
Directeur/Bestuurslid bij Biotechnology & Biological Sciences Research Council
Actieve functies van Fiona Angela Marston
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Directeur/Bestuurslid | - | - |
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Erebagen Ltd. is a British company founded in 2020 that develops novel bioactive products from microbes by activating previously silent gene clusters. The company is based in Coventry, UK. | Directeur/Bestuurslid | 01-04-2022 | - |
Loopbaan van Fiona Angela Marston
Eerdere bekende functies van Fiona Angela Marston
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
H2O Venture Partners Ltd.
H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners Ltd (H2O Venture Partners) is a private equity subsidiary of H20 Venture Partners (Manager) LLP founded in 2006 by David Kelly and Coleman Paul. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 01-04-2008 | 01-07-2011 |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Algemeen Directeur | 07-12-2010 | - |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Medella Therapeutics Ltd. develops monoclonal antibody drugs for cancer. Its focus is on cancer, where the unmet need is for therapies that preferentially target cell signaling in cancer cells, offering advantages over drugs marketed and in clinical development. The company was founded by Kim Skerry and Gareth Richards in May 2007 and is headquartered in Sheffield, the United Kingdom. | Directeur/Bestuurslid | 11-08-2010 | - |
Corporate Officer/Principal | - | 11-08-2010 | |
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Oprichter | - | - |
President | - | - |
Opleiding van Fiona Angela Marston
University of Kent | Doctorate Degree |
London Business School | Masters Business Admin |
University of East Anglia | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 10 |
Operationeel
Director/Board Member | 3 |
Founder | 1 |
President | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 4 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 6 |
---|---|
Novacta Biosystems Ltd.
Novacta Biosystems Ltd. BiotechnologyHealth Technology Novacta Biosystems Ltd. discovered and developed drugs for treatment of bacterial infections. Its products included lantibiotic/bacteriocin variants, as well as a development candidate for the treatment of C. difficile infection. The company was founded by John Michael Dawson on February 14, 2015 and was headquartered in London, the United Kingdom. | Health Technology |
Medella Therapeutics Ltd.
Medella Therapeutics Ltd. BiotechnologyHealth Technology Medella Therapeutics Ltd. develops monoclonal antibody drugs for cancer. Its focus is on cancer, where the unmet need is for therapies that preferentially target cell signaling in cancer cells, offering advantages over drugs marketed and in clinical development. The company was founded by Kim Skerry and Gareth Richards in May 2007 and is headquartered in Sheffield, the United Kingdom. | Health Technology |
H2O Venture Partners Ltd.
H2O Venture Partners Ltd. Investment ManagersFinance H2O Venture Partners Ltd (H2O Venture Partners) is a private equity subsidiary of H20 Venture Partners (Manager) LLP founded in 2006 by David Kelly and Coleman Paul. The firm is headquartered in London, United Kingdom. | Finance |
Absynth Biologics Ltd.
Absynth Biologics Ltd. BiotechnologyHealth Technology Absynth Biologics Ltd. develops and manufactures immunological prophylaxis, novel vaccines and therapies. The company was founded by Simon J. Foster in 2007 and is headquartered in Alderley Edge, the United Kingdom. | Health Technology |
Biotechnology & Biological Sciences Research Council
Biotechnology & Biological Sciences Research Council Miscellaneous Commercial ServicesCommercial Services Biotechnology & Biological Sciences Research Council operates a funding agency for academic research and training. It funds bioscience, people and research infrastructure that helps to tackle major challenges such as the impact of climate change, a healthier old age, and sustainable food production, land use and energy production. The company is headquartered in Swindon, the United Kingdom. | Commercial Services |
Erebagen Ltd.
Erebagen Ltd. BiotechnologyHealth Technology Erebagen Ltd. is a British company founded in 2020 that develops novel bioactive products from microbes by activating previously silent gene clusters. The company is based in Coventry, UK. | Health Technology |